Pleriksafor Teva 20 mg/ml otopina za injekciju
| Name | Pleriksafor Teva 20 mg/ml otopina za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-485257144 |
| Active Substance | pleriksafor |
| Composition | 1 ml otopine za injekciju sadrži 20 mg pleriksafora jedna bočica sadrži 24 mg pleriksafora u 1,2 ml otopine |
| Pharmaceutical Form | otopina za injekciju |
| Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
| Marketing Authorisation Holder | TEVA GmbH, Graf-Arco-Str. 3, Ulm, Njemačka |
| Marketing Authorisation Date | 29.03.2023 |
| MA Period of Validity | 29.03.2028 |
| Classification Number | UP/I-530-09/21-01/230 |
| Registration Number | 381-12-01/171-23-06 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L03AX16 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
